Home | Recruitment

Complete

Trials by recruitment status

Public Title Date of registration Sponsor
Effectiveness and Safety of use ior LeukoCIM as prophylaxis and treatment of Neutropenia in patients with HIV / AIDS. 2009-08-20 CIMAB
Safety assessment of Granulocyte Colony Stimulating Factor:ior LeukoCIM in oncohematologic patients.Phase IV study. 2009-07-24 CIMAB
Impact of the Granulocytes Colony-Stimulating Factor (ior-LeukoCIM) in primary and secondary prophylaxis and post chemotherapy and/or radiotherapy neutropenia in oncohematological pediatric patients. 2009-07-24 CIMAB
Effectiveness and Safety of ior EPOCIM in patients with Chronic Renal Failure on dialysis methods. 2009-07-10 CIMAB
Therapeutic Equivalence between ior EPOCIM and EPO without albumin, for patients with Chronic Renal failure on Peritoneal dialysis methods.(Hemodialysis or peritoneal dialysis). 2009-07-03 CIMAB
Impact of Human Recombinant Erithoropoietin (ior EPOCIM) in cancer patients with post Chemo and Radiotherapy induced anemia. 2009-07-03 CIMAB
Impact of Recombinant Human Erythropoietin (ior EPO-CIM) in oncology pediatric patients with post chemo and /or radiotherapy. 2009-07-03 CIMAB
Amniotic Membrane Transplantation vs Conjunctival–Limbal Autograft for Primary Pterygium 2009-07-03 HHA
Extract of Mangifera indica L. (Vimang®)-Ischemic Stroke 2009-03-13 CQF
Evaluation of the neuroprotector effect of an extract of stem bark of Mangifera indica L. (Vimang®) in patient with Spinocerebellar Hereditary Ataxia Type 2 2009-03-13 CQF
Effect of the supplementation with Vimang ® on indicators of oxidative stress in young people with Diabetes Mellitus type 1. 2009-02-27 CQF
Extract of Mangifera indica L. (Vimang®)- Third age- Phase II. 2009-02-27 CQF
Safety and immunogenicity of commercial Hepatitis B vaccines. 2009-02-27 CIGB
CITOPROT-III 2009-02-26 CIGB
Evaluation of the antiinflammatory effect of the Vimang® cream in patients with Dermatitis chronic disease. 2009-02-12 CQF
Recombinant interferon alpha-2b in paranoid schizophrenia. 2009-02-11 CIGB
Recombinant IFN alpha-2b for relapsing –remitting multiple sclerosis. 2009-02-11 CIGB
THERESA 2008-10-07 CIGB
FarmaPEG-I 2008-10-07 CIGB
Cutaneous Use of Tisuacryl® 2008-09-30 BIOMAT